mBrain-21 : a Three-month Study on Context-awareness, Physiological Monitoring, and Machine Learning in Migraine and Cluster Headache

Last updated: February 5, 2024
Sponsor: University Hospital, Ghent
Overall Status: Completed

Phase

N/A

Condition

Acute Pain

Trigeminal Neuralgia

Oral Facial Pain

Treatment

Wearable sensor and smartphone application

Clinical Study ID

NCT04983186
BC-10031
  • Ages 18-65
  • All Genders

Study Summary

This study collects data from migraine and cluster headache patients during a three-month study. Contextual data (e.g. location or smartphone usage) and physiological variables will be used to assist machine learning algorithms in making predictions on activity, stress and sleep in patients with migraine or cluster headache.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adult participants between the age of 18 en 65 years.
  • Diagnosis of migraine without aura (ICHD-3 diagnosis 1.1) or migraine with aura (ICHD-3 diagnosis 1.2) or chronic migraine (ICHD-3 diagnosis 1.3)
  • Headache crystal clear days on minimum 5 days per month on average.
  • Onset of headache syndrome before the age of 50.
  • Attacks of migraine or cluster headache are clearly distinguishable from other typesof headache disorders if present.
  • Participant complies with protocol to use smartphone applications on his or her ownAndroid-based smartphone (minimum version 8.0) and to provide access to his or hersmartphone dataplan.

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Wearable sensor and smartphone application
Phase:
Study Start date:
July 19, 2021
Estimated Completion Date:
September 07, 2023

Study Description

Migraine and cluster headache are brain disorders with disabling headache attacks and assoicated symptoms. Attacks have multiple phases such as the premonitory phase, aura phase, headache phase and postdromal phase. During those phases, symptoms of homeostatic disturbance or sensory alterations may occur.

The goal of the study is to observe activity, stress and sleep parameters in relation to registered headache attacks.

Participation in the mBrain-21 study will last maximum 90 days. Participants are patients with migraine or cluster heacache recruited within the headache clinic of Ghent University Hospital. Physiological variables such as heart rate, movement and galvanic skin resonse will be measured by the Empatica E4 wrist sensor. Patient-specific experiences during headache attacks and activities of daily life will be registered with a custom-made headache smartphone applications. Contextual data (e.g. smartphone usage or location) can be autonomously collected through smartphone applications.

Connect with a study center

  • University Hospital, Ghent: Department of Neurology

    Ghent, 9000
    Belgium

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.